Healthcare associated infections in COVID-19 patients

Healthcare associated infections in COVID-19 patients

COVID-19 patients suffering from severe forms of the disease are at risk of developing bacterial healthcare-associated infections, such as ventilator-associated pneumonia caused by multidrug resistant pathogens. TP-122 bacteriophage cocktail may be an alternative for...

TechnoPhage is hiring for Head of Neuroscience

TechnoPhage is currently looking for a Head of Neuroscience/Ophthalmology (PhD) with a strong scientific background to lead a team dedicated to characterize and understand the function of therapeutics against a large range of targets. Click here to know...

New patent addressing Parkinson’s disease allowed in the USA

The United States Patent and Trademark Office recently issued a notice of allowance for US patent application number 15/568,655 covering Technophage’s TZ-113 project. TZ-113 is a repurposing project for Parkinson’s patients targeting levodopa induced...

ChinaBio® Partnering Forum

TechnoPhage’s CEO Miguel Garcia will attend the 11th Annual International Partnering Conference ChinaBio® Partnering Forum on May 8-9 in Shangai, China. If you wish to meet us at the conference feel free to contact us to info@technophage.pt to schedule a...